Abstract | As age at pubertal onset declines and age at first pregnancy increases, the mechanisms that regulate female reproductive lifespan become increasingly relevant to population health. The timing of menarche and menopause can have profound effects not only on fertility but also on the risk of diseases such as type 2 diabetes mellitus, cardiovascular disease and breast cancer. Genetic studies have identified dozens of highly penetrant rare mutations associated with reproductive disorders, and also ~175 common genetic variants associated with the timing of puberty or menopause. These findings, alongside other functional studies, have highlighted a diverse range of mechanisms involved in reproductive ageing, implicating core biological processes such as cell cycle regulation and energy homeostasis. The aim of this article is to review the contribution of such genetic findings to our understanding of the molecular regulation of reproductive timing, as well as the biological basis of the epidemiological links between reproductive ageing and disease risk.
Introduction
The timing of reproductive ageing in women varies sub stantially in the general population, which has pro found social, economic and clinical consequences. [1] [2] [3] [4] The repro ductive lifespan in women can be defined as the time between the onset of puberty and oocyte deple tion at menopause. The first signs of puberty typically occur around 8-13 years of age, 5 with a broader window of menopausal timing between the ages of 40 and 60 years old. 6 In rare cases, these timings are disrupted. Around 1% of women have primary ovarian insufficiency (POI), which is defined as the occurrence of menopause before 40 years of age. 7 Natural fertility declines on average 10 years before menopause, and the effect of early meno pause on infertility is increasing as maternal age at child birth steadily rises in many Western populations. 8, 9 At the start of the reproductive lifespan, precocious, delayed or absent puberty are disorders associated with adverse physiological and psychological consequences. 10, 11 Within these extremes, normal vari ation in reproduc tive ageing is associated with the risk of a wide range of disease outcomes. These outcomes have been described in epidemiological studies that recorded the timing of wellrecalled reproductive ageing milestones, such as age at menarche (first menstrual bleed) and age at natural menopause (in women without surgical or medical causes of oocyte depletion).
Until the past few years, little genetic overlap existed between the loci or genes identified for the timing of puberty and menopause. However, new statistical gen etics techniques have estimated a modest shared genetic aetiology for the timing of these events, 12, 13 and these estimates are supported by new epidemiological evi dence linking these two traits.
14 Furthermore, in a number of genomewide association studies (GWAS), loci identified as being associated with age at natural menopause are located in or near genes that regulate the hypothalamic-pituitary-gonadal axis (such as CHD7, FGFR1, SOX10, KISS1 and TAC3), 13 which suggests that some mechanisms regulate both puberty and menopause.
The widely reported links between reproductive ageing and other health outcomes have prompted a number of research questions. Firstly, what biological processes and which genes contribute to the wide population variance in reproductive timing? In turn, which of these processes link reproductive ageing to disease? Lastly, can genetic tools help to identify individuals at high risk of abnor mal reproductive ageing in order to inform their health and reproductive choices? This issue is particularly rele vant for early menopause, for which accurate prediction is currently only possible within 5 years of the event. This Review aims to describe how genetic studies have pro vided molecular insights into the aetiology of female reproductive ageing, illustrating key findings that have transformed our understanding of reproductive ageing and its relevance to disease.
Genetic architecture
The identification of genes that regulate reproductive function has been informed by targeted DNA sequen cing in individuals with rare disorders of reproduc tive timing and, in the past decade, by largescale array genotyping of single nucleotide polymorphisms in populationbased studies.
Rare Mendelian disorders
Clinical cases of idiopathic hypogonadotropic hypo gonadism (IHH; delayed or absent puberty) or POI have long been studied using DNA sequencing. For each condition, around 20-30 genes have been identi fied ( Figure 1) ; these genes have autosomal dominant, autosomal recessive, Xlinked and oligogenic inheri tance patterns. A sizable fraction of IHH cases (around 30-40%) are explained by such gene defects; however, the proportion is much lower for POI (~10%), with expanded triplet repeats in FMR1 or other Xchromosomal abnor malities found in only ~5% of patients. The identifica tion of genetic causes of central precocious puberty is even more difficult, with the identification of paternally inherited lossoffunction mutations in MKRN3 38 using wholeexome sequencing adding to reported activating mutations in KISS1 and KISS1R. 39 In the past year, rare pathogenic mutations for IHH have also been impli cated in the aetiology of less severe, selflimiting delayed puberty, 40 which raises the question of whether such pathogenic mutations might contribute to the normal population variance in the timing of puberty.
Population-based studies
In a complementary populationbased approach, GWAS have now identified ~150 distinct genomic loci associ ated with the timing of puberty or menopause. These studies are designed to identify common genetic vari ants, each with a small effect, which in aggregate could contribute substantially to the wide variation in repro ductive ageing in the general population (Table 1) . Individual effect sizes for common variants (minor allele frequency [MAF] >5%) range from ~2 weeks to ~5 weeks for age at menarche, 41 with similar estimates obtained from followup studies of the timing of breast develop ment and other physical changes of puberty. 42 Low frequency variants (defined as MAF 1-5%) in ALMS1 have the largest reported effect on the timing of puberty in normal populations-the rare allele delays menarche by ~3 months. 43 For age at menopause, 56 common or lowfrequency variants have been reported, with effect sizes ranging from 0.07 years to 0.88 years per allele. 13 In aggregate, these loci explain only a small proportion of the population variance for each trait (~5%); however, Key points ■ The genetic architecture of pubertal timing and age at menopause involves hundreds of rare, low frequency and common variants, with allelic heterogeneity often apparent at the same loci ■ Progress in localizing these variants has shed light on the wide range of biological mechanisms that regulate these traits, including energy homeostasis, gene silencing and DNA repair ■ Population variability in age at menarche and menopause is associated with altered health outcomes in later life, notably earlier timings increase the risk of type 2 diabetes mellitus and cardiovascular disease ■ Mechanisms that link reproductive ageing to metabolic diseases involve both obesity-related pathways and pathways independent of BMI ■ Exposure to sex hormones is probably the overwhelming mechanism linking reproductive ageing to the risk of breast cancer and other hormone-sensitive cancers statistical modelling suggests that common genetic vari ation (when eventually fully characterized) will explain a substantial component of trait heritability. The genetic architecture of these traits probably involves tens of thou sands of variants, potentially implicating hundreds if not thousands of genes. GWAS benefit from a 'hypothesisfree' approach to gene identification, utilizing the properties of linkage disequilibrium-the high correlation between inherited variants-to ensure broad coverage across the genome. The drawback of linkage disequilibrium is the uncer tainty regarding the identity of causal genes and vari ants in associated genomic regions (loci). This limitation is compounded by the difficulty in experimentally testing large numbers of genes or variants using high throughput methods sensitive enough to detect the probably small molecular effects. Despite these limita tions, genomic and bioinformatics approaches can help to map plausible causal genes. In turn, pathway analyses across groups of plausible genes can powerfully impli cate important aetiological mechanisms, which remain important even if a few of the mapped genes are incor rect. For example, 29 of the 44 genomic regions identi fied for age at menopause map in or near genes involved in the DNA damage response (DDR), including 18 loci for which the DDR gene candidate is either the nearest or is linked via altered mRNA expression levels (expres sion quantitative trait loci). 13 This degree of enrichment far exceeds that expected by chance, and would remain significant even if some candidate DDR genes were incorrectly mapped.
Allelic heterogeneity
Considerable allelic heterogeneity and overlap exists across many of the genes identified for reproductive timing ( Figure 2) . Notable examples include the report of autosomal recessive lossoffunction alleles in TACR3 as a fairly frequent finding in patients with IHH, 44 whilst haploinsufficiency of the same TACR3 alleles is associ ated with a pubertal delay of ~1.25 years in the general population; 43 common variants (MAF ~15%) near this gene have a much smaller (~2.5 week) effect than haplo insufficiency. 41 Similarly, lossoffunction mutations in KISS1R cause IHH, whereas gainoffunction mutations cause the opposite phenotype of precocious puberty. 39 Interestingly, common variants associated with meno pausal timing map within ~50 kb of this gene. 13 The DNA helicase B gene (HELB) locus contains multiple statistically independent common variants associated with menopausal timing, in addition to harbouring low fre quency and high penetrance missense alleles. 13 Common variants and rare alleles at the imprinted gene MKRN3 cause physiological vari ation and rare clin ical disorders of puberty, respectively, and both types exhibit paternalspecific parentoforigin effects. 38, 41 Furthermore, overlap exists between common loci for reproductive timing and genes disrupted in rare syn dromes in which disordered reproductive ageing is one of several clin ical features; these genes include IGSF1 45 and PCSK1 46 ( Figure 2 ).
Characterization of rare monogenic disorders and physiological variation in normal populations (as described previously in this Review) will probably yield further overlaps as technology evolves. The allelic heterogeneity observed at many loci suggests that tar geted DNA sequencing at GWAShighlighted genes in patients with reproductive disorders will yield novel molecular diagnoses. Eventually, the comprehensive cataloguing of all genetic variation-common, rare and complex-in very large populationbased studies will lead to improved estimates of genetic penetrance, and will enable evaluation of the effect of common variation on extreme phenotypes, as well as the effect of rare variants on common phenotypes. Ultimately, improved understanding of the genetic architecture of reproductive ageing across the full phenotypic spectrum could lead to the accurate prediction and classification of disease states informed by genotype.
Biological mechanisms
Energy homeostasis and reproductive ageing Epidemiological studies consistently report links between earlier age at menarche and increased BMI or risk of obesity. A causal relationship between these traits is strongly supported by their strong genetic corre lation. 12 Almost all of the BMIincreasing alleles reported in GWAS also have effects on earlier timing of menarche. 41, 47 These effects are directionally concordant with the traditional epidemiological association between increased BMI and earlier age at menarche 48 and support the presence of a general mechanism linking weight status to pubertal timing and reproductive function ( Figure 3 ). Leptin, an adipokine with potent appetite suppressing central actions, has been proposed as such a general mechanism. Rare deleterious mutations in the leptin gene (LEP) cause severe early onset obesity associ ated with hypogonadotropic hypogonadism; 49 however, leptin therapy enables normal pubertal timing rather than precocious puberty, 50 which indicates that leptin has permissive rather than direct actions. In the past year, a lowfrequency missense variant in PRKAG1 has been associated with earlier age at menarche.
43 PRKAG1 encodes the γ1 regulatory subunit of AMPactivated protein kinase, which senses and maintains cellular energy homeostasis by promoting fatty acid oxidation and inhibiting fatty acid synthesis. The identification of specific fatty acids that activate pituitary gonadotropes is a topic of ongoing investigation. 51 Insulin has various peripheral actions that promote sex hormone secre tion (from gonads and adrenal glands), aromatization (in adipocytes) and bioavailability and could, therefore, potentially link weight status to pubertal timing.
Other evidence shows that many GWASidentified loci for adult BMI influence weight gain and adiposity from infancy and early childhood, 52 which is consistent with the established dependence of hypothalamic-pituitarygonadal axis activity on energy balance, although the causal relationship between BMI and pubertal timing might yet be bidirectional. Notable exceptions to this model of shared biological mechanisms include GWAS identified loci at MC4R and the leptin receptor gene (LEPR). Despite a fairly large effect on BMI, evident in children of both sexes, MC4R variants are unrelated to pubertal timing in girls, 41, 47 although a possible associ ation has been reported in boys. 42 By contrast, the GWASidentified locus at LEPR influences pubertal timing but not adult BMI, indicating a possible addi tional role for the leptin pathway outside its established actions on energy homeostasis.
In contrast to pubertal timing, the epidemiological relationship between BMI and the timing of natural menopause has been less clearly described. Systematic HESX1  GNRH1  MKRN3  GNRHR FSH  NR5A1 P1  LHLEP  TACR3 TAC3  SOX2  PROP1 LHR  RNF216 KISSR  LEPR FSHR  KISS1   DAX1   KAL1  POLR3A   TACR3   LAMB2   TNRC5A   ALMS1   HELB   SLCO4A1   MSH5  MCM9   POLG  NOBOX  PGRMC1  SYCE1  STAG3  EIF2B4  NR5A1   BMP15  POF1B  DIAPH2  DMC1  FIGLA   MCM8  FSHR  EIF2B2  FOXL2  HFM1  LHR  EIF2B5   MCM8 REVIEWS reviews describe a potential mildly protective effect of overweight and obesity on the risk of early menopause, although with moderate heterogeneity between studies and variable consideration of smoking and other poten tial confounders. 53, 54 A large GWAS published this year reported significant inverse genomewide genetic corre lations between age at natural menopause and adult obesity (genetic correlation [r g ] = −0.15, P = 0.0004) and adult BMI (r g = −0.13, P = 0.003), 13 which support a shared aetiological basis, but the actual mechanisms linking increased BMI to late menopause are unclear.
Hypothalamic-pituitary-gonadal axis
Delineation of the central hypothalamic-pituitarygonadal axis that regulates gonadal sex steroid produc tion and fertility has been largely informed by studies of monogenic reproductive disorders (Figure 3 ). Rare muta tions that disrupt the embryonic migration from the nasal placode of cells that produce hypothalamic gonadotropin releasing hormone (GnRH) cause Kallmann syndrome (hypogonadotropic hypogonadism associated with anosmia). 15 Other rare mutations more specifically disrupt GnRH cell function, for example, those in KISS1, TAC3, GNRH1 and in genes encoding their receptors KISS1R, TACR3 and GNRHR. Central hypogonad ism is also a consequence of mutations that disrupt the develop ment of pituitary gonadotropes, such as those in HESX1 and SOX2, or mutations in genes that encode the pituitary hormone folliclestimulating hormone (FSH) βsubunit 55 or its receptor (FSHR). 56 Conversely, MKRN3 is a paternally expressed gene enco ding a hypo thalamic repressor of pulsatile GnRH secretion (probable E3 ubiquitinprotein ligase makorin3). 38 The (expected) concordance between the mecha nisms that underlie rare reproductive disorders and those that contribute to population variance in repro ductive timing has been demonstrated by the enrich ment of robustly associated genomic variants (that is, GWAS signals) for age at menarche in or near genes that underlie monogenic disorders of puberty. 41 These include age at menarche GWAS signals in or near genes that regulate GnRH cell function (MKRN3, GNRH1, TACR3 and LEPR), hypothalamus or pituitary develop ment (POU1F1 and TENM2) or pituitary hormone processing (PCSK1 and PCSK2), as well as other signals with potential roles in hypothalamic or pituitary develop ment (FRS3, LGR4 and TBX6). 41 Furthermore, an age at menarche GWAS signal has been reported on the X chromosome at the location of the IGSF1 gene. 43 Rare Xlinked mutations in IGSF1 cause central hypo thyroidism, hypoprolactinaemia, delayed puberty and macroorchidism in male patients, but a yet uncertain reproductive pheno type in hetero zygous female indivi duals. 45, 57 Age at menarche GWAS signals have been detected in or near the retinoic acidrelated hormone receptors RXRG and RORA, and signals with subgenome wide significance have been detected in or near RXRA, RORB and RXRB. The encoded proteins could mediate effects of retinoic acid signalling on GnRH secretion 58 or could regulate other hormone receptor sensitivities. For these selected genes, variants were identified in population-based studies that had an effect on either age at menarche or age at menopause.*Common refers to a population MAF >5%, low frequency to a population MAF 1-5% and rare to a population MAF <1%. ‡ Per allele effect size based on test statistics from GWAS discovery meta-analysis. § Evidence type supporting this gene being causal at the locus highlighted by GWAS. Abbreviations: B, supporting biology; E, linked via altered expression to the associated SNP (expression quantitative trait loci); F, the lead SNP (or a strongly correlated proxy) is a missense variant in this gene; GWAS, genomewide association study; M, reported monogenic mutations for associated disorders in the gene; MAF, minor allele frequency; N, nearest gene to the association signal; SNP, single nucleotide polymorphism.
A more surprising genetic finding has been the rele vance of central components of the hypothalamicpituitary-gonadal axis to the population variance in menopausal timing. GWAS loci for age at menopause are enriched in or near genes implicated in monogenic dis orders of puberty, with five signals in or near genes disrupted in hypo gonadotrophic hypogonadism (KISS1R, TAC3, CHD7, SOX10 and FGFR1). A further age at meno pause GWAS signal in or near FSHB is associated with circulating FSH levels. Previously, the menopausal rise in hypothalamic and pituitary hormone secretion was thought to be a passive consequence of loss of sex steroid feedback inhib ition. 59 Although it is possible that the implicated proteins also have peripheral actions directly on the ovary, 60 increasing evidence suggests that central neural control is involved in r eproductive ageing.
Gene silencing
The hypothalamic-pituitary-gonadal axis (Figure 3 ) is already active in utero and during early infancy-hence, as well as requiring the maturation of excitatory com ponents, the onset of puberty might be mediated by the silencing of repressive factors that are active during child hood. 61 Evidence to support this model has been reported in animal studies and human GWAS findings, which are described later in this article.
The first GWAS for age at menarche identified common variants in LIN28B, which encodes Lin28B-a potent and specific regulator of let7 microRNA pre processing. [62] [63] [64] [65] Let7 microRNAs are developmental stagespecific posttranscriptional silencers of numer ous target genes. The Lin28B-let7 axis maintains cell pluripotency, 66 and has been shown in experimen tal models to regulate pubertal development, glucose metabolism, tissue repair and cancer risk. 67 Subsequently, an exonfocused study for age at menarche identified a lowfrequency missense variant in TNRC6A associated with delayed age at menarche. 43 TNRC6A encodes an Argonautenavigator protein, which, akin to the Lin28B-let7 axis, is responsible for posttranscriptional gene silencing through a variety of RNA interference and microRNA pathways. 68 A GWAS for age at menarche in women published in 2014 identified an enrichment of associated regions in or near known imprinted genes, 41 whose expres sion is silenced by stable DNA methylation marks that are determined by the parental origin of the alleles. Specifically, genomewide significant signals for age at menarche were located at three imprinted gene regions, MKRN3-MAGEL2, DLK1 and KCNK9. For these signals, the associations were dependent on the parental origin of alleles, consistent with expression patterns. Thus, at the maternally imprinted (silenced) loci (MKRN3-MAGEL2 and DLK1) only the paternally inherited alleles, but not the maternally inherited alleles, were associated with age at menarche, and vice versa for the paternally imprinted locus, KCNK9. These findings suggest possible parental originspecific selection advantages of alleles that regulate reproductive timing.
An elegant model of epigenetic repression of the hypothalamic-pituitary-gonadal axis has been described in female rats. 69 Towards the onset of puberty, DNA methy lation decreases the hypothalamic expression of two key Polycomb group genes, Eed and Cbx7, in key hypothalamic neurons. As well as decreasing levels of the encoded repressive EED and CBX proteins, an increase in activating histone modifications probably also con tributes to the upregulation of Kiss1 expression and the onset of pulsatile GnRH secretion. The relevance of this epigenetic model in humans is supported by GWAS findings, which have identified a menarcheassociated locus at CBX7 as well as strong enrichment of menarche associated signals near genes that encode activating JumonjiCdomaincontaining histone demethylases. 41 Establishing the oocyte pool The central dogma of reproductive biology is that the oocyte pool is finite and oocytes produced during fetal development steadily apoptose throughout life until menopause (Figure 4 ). This principle has been chal lenged by experiments that have demonstrated the pres ence of ovarian stem cells in mice and humans, which can be experimentally manipulated to generate func tional oocytes. [70] [71] [72] Primordial germ cells migrate to the gonadal ridge during week 6 of development when the diploid germ cells are termed oogonia. 73 Multiple rounds of mitosis generate a pool of ~7 million oogonia by 6 months gestation. Meiosis starts at around gesta tional week 11-12, such that the fetal ovary contains a mixture of both mitotic and meiotic germ cells. Oocytes are arrested in the first meiotic division until ovulation, many years later. 74 This process is controlled by cAMP secreted by the surrounding granulosa cells in the ovary. Atresia of oocytes begins during fetal life and continues until meno pause, with only a few hundred oocytes lost through ovu lation. Whether stem cells in the human ovary contribute to the physio logical follicle pool has yet to be determined. The possi bility exists that stem cells generate oocytes continually throughout life, but that the process contributes minimally to the overall pool and becomes inefficient with age and is, therefore, not sufficient to prevent meno pause. 75 However, the pres ence of stem cells in human ovaries has generated sub stantial interest in relation to the possibility of activating oogenesis in women with poor ovarian reserve, or for improving fertility preservation techniques in women undergoing chemotherapy.
Meiosis and nondisjunction
As women age, the risk of chromosomal abnormalities in their offspring increases substantially, along with the risk of miscarriage, as a result of errors in chromosomal segregation (nondisjunction) resulting in aneuploidy. The majority of nondisjunction errors occur during mater nal meiosis 1, when meiosis resumes following puberty, and maternal age is a major risk factor. 76 However, it is still not clear what underlying molecular mechanism explains why female meiosis is more prone to errors than male meiosis and why age has such a large effect on the likelihood of errors. In 1968, Henderson and Edwards proposed the 'production line hypothesis' of oogenesis, which suggests that oocytes are ovulated in the order in which they are produced and that recombination rates are higher in oocytes entering meiosis in an earlier stage of the reproductive lifespan than oocytes going through meiosis at a later stage. 77 Evidence exists in animal models and humans to support the first element of the production line hypothesis, that oocytes are ovulated in the order in which they are produced. 78, 79 However, the role of ovarian ageing is less clear. Recombination rates are certainly a risk factor for nondisjunction and are much more variable in women than in men, which might explain why female meiosis is more error prone than male meiosis. However, the role of recombination rates in ovarian ageing is less clear, as studies in human fetal ovarian tissue suggest that rates do not vary substantially with age. 80 The maternal age effect could instead reflect the age related decline in oocyte expression of cohesin, a complex that tethers sister chromatids during meiosis. Recessive mutations in STAG3, a gene that encodes a component of the cohesin complex, and a mouse knock out model demonstrate that this complex is essential for oocyte development. Individuals with mutations in STAG3 present with primary amenorrhoea and mutant mice show meiotic arrest in the leptotene stage, with ovaries devoid of follicles by 1 week of age. 34 The synapto nemal complex is another key chromosome maintenance struc ture in meiotic recombination. The complex is composed of three different protein subunits and is involved in homologous chromosome pairing. A non sense mutation in SYCE1, which encodes a com ponent of this complex, has been described in a con sanguineous family; two sisters with the homozygous mutation had primary amenorrhoea, but one had normal pubertal timing and the other had delayed puberty. 81 Thus, it seems that main tenance of chromosome pairs during meiosis is essential for both correct segregation of chromosomes and for oocyte viability.
DNA damage repair
Genetic studies have highlighted the substantial role of DDR mechanisms in ovarian ageing, reflecting the susceptibility of oocytes to DNA damage throughout life.
82 Doublestrand DNA breaks accumulate with age in human and mouse ovarian follicles, with concomitant downregulation of the key DNA repair genes BRCA1, MRE11, RAD51 and ATM. 83 Doublestrand break repair also resolves the chromatid crossovers that result from recombination in meiosis 1; thus, inefficient repair could also result in oocyte loss during early development. About twothirds of GWAS loci for menopausal timing contain DDRrelated genes. 82 In addition, several examples exist of rare monogenic mutations in DDR genes causing early menopause or POI. 26, 35, 36 Carriers of cancerpredisposing mutations in the DDR genes BRCA1 and BRCA2 enter natural menopause earlier than noncarriers. 84, 85 Recessive mutations in two gene members of the mini chromosome maintenance family (MCM8 and MCM9) segregate with the POI phenotype in three large con sanguineous kindreds. 35, 36 Concordantly, a GWAS locus at MCM8 has a fairly large effect on normal menopausal timing, with each minor allele increasing menopausal age by ~1 year. 82 Fibroblasts and lymphocytes cultured from patients with POI and mutations in MCM8 or MCM9 display chromosomal instability. Both MCM8 and MCM9 mutations inhibit the formation of foci at the site of doublestrand breaks. MCM8 and MCM9 form a complex with each other at sites of doublestrand breaks and recruit RAD51 to promote homologous recombina tion repair. 86 Mouse knockout models of these two genes Nature Reviews | Endocrinology
Energy sensing
Sensing of suf cient body energy stores is necessary for both the onset of puberty and adult reproductive axis activity.
Gene silencing
The hypothalamic-pituitarygonadal axis is active during fetal life and infancy, and is repressed during pre-pubertal childhood.
Silencing of the repressors enables onset of puberty.
Hypothalamus and pituitary
Pulsatile secretion of GnRH by hypothalamic neurons stimulates the secretion of gonadotropins (FSH and LH), which in turn stimulate gonadal hormone production.
The oocyte pool
The nonrenewable oocyte pool is established during fetal life, diminishes primarily through cell death and is preserved by DNA damage sensing and repair mechanisms. show gonadal failure and chromosomal instability, which demonstrates the key role of doublestrand break repair in oocyte survival. 87 Other DDR processes are implicated in ovarian ageing. Mitochondrial function might influence ovarian reserve through accelerated apoptosis. Mutations in three genes that encode mitochondrial proteins result in Perrault syn drome, which is characterized by POI or primary amen orrhoea plus sensorineural hearing loss. [88] [89] [90] Increased oocyte apoptosis is also the proposed mech anism by which FMR1 expansion limits reproductive lifespan. Women with POI have a fivefold higher risk of carrying an FMR1 gene with 55-200 copies of the polymorphic CGG repeat sequence ('premutation' allele) than the general population. 37 Mouse models show that the CGG repeat expansion acts through a RNAmediated mechanism, which results in atresia of developing follicles, rather than a limited primordial oocyte pool size. 91, 92 Whether women with premature ovarian ageing have more generalized premature ageing is not known. Women with progeria syndromes, such as Hutchinson-Gilford syndrome or Werner syndrome, often exhibit premature menopause or primary hypogonadism. 93 DDR mech anisms might contribute to the epidemio logical links between early age at menopause and the risk of other agerelated diseases.
Autoimmunity
In 10-30% of patients with POI, an autoimmune aetiology is suspected, as indicated by detectable anti ovarian anti bodies or cosegregation with an established auto immune disorder, such as thyroiditis or type 1 diabetes mellitus. 94 However, unlike most other auto immune dis orders, no robust evidence exists for an HLA haplotype association with POI or age at natural menopause. 95, 96 A GWAS locus for age at natural menopause is located in the HLA region on chromosome 6, but association with specific HLA haplotypes has yet to be confirmed. 82 Other GWAS loci suggest a role in reproductive ageing for the immunity related genes IL11 and NLRP11. 13 Female mice with null mutations in the Il11 receptor gene are infertile due to defective uterine decidualization. 97 The NLR gene family regulates both innate immunity and reproduction. Several NLR genes show an oocytespecific expression pattern 97 and NLRP5 has been implicated in POI and encodes an autoantigen in a mouse model of autoimmune POI. 98, 99 Links to other health-related traits Numerous epidemiological studies have linked the timing of reproductive ageing to various adverse health outcomes; however, in many cases, the causal nature of these associations and their underlying mechanisms are unclear. Supporting evidence from genetic analy tical modelling can help to reduce confounding and avoid recall bias. Furthermore, the identification of shared biological mechanisms between two traits supports the existence of causal relationships. In addition to the strong genetic correlation between increased BMI or obesity risk and earlier pubertal timing (described previously in this article), genetic findings support other mech anisms that could explain the observed links between reproductive ageing and other healthrelated traits. 
Anthropometric traits
The shared genetic architecture between pubertal timing and adult height reflects the complex relationships between these traits. Girls who reach puberty early are consistently taller than other girls during early and mid childhood, but due to earlier cessation of growth are usually shorter as adults. 100 Use of an analytical method, linkage disequilibrium (LD) score regression, identified an overall positive genomewide genetic correlation between age at menarche and adult height (r g = 0.11, P = 6 × 10 −5 ), 12 which supports the causal nature of the overall epidemiological associ ation. 100 Directionally consistent with that obser vation, the menarche age raising alleles at two GWAS loci (LIN28B and SIX6) were also associated with taller adult height. 41 These genes have plausible regulatory functions in reproduc tive maturity. The role of Lin28B in gene silencing and repressing developmental regulation was described in a previous section of this article. SIX6 encodes a homeo domain transcription factor that regulates the tran scription of gonadotropespecific genes in pituitary gonadotrope cells. 101 Conversely, at the GWAS locus, CENPW, which encodes an RNAassociated nuclear matrix protein, the menarche ageraising allele was associ ated with reduced adult height, 41 which is direc tionally discordant with the overall observed associ ation. Furthermore, this variant was the only age at menarche GWAS signal to be associ ated with the auto immune disorder type 1 diabetes mellitus. 41 These diverse associations might indicate multiple pleiotropic roles of this specific CENPW locus on growth, pubertal timing and disease risk. By contrast, no overlap exists between GWAS loci identified for age at menopause and height and no genetic correlation exists between these traits (r g = 0.006; P = 0.88). 13 The GWAS locus near LEKR1 and CCNL1 is common to pubertal timing, 41 birth weight 102 and central adipos ity (waisttohip ratio adjusted for BMI). 103 At this locus, the menarche ageraising allele also confers increased birth weight and greater central adiposity, consistent with the epidemiological associations between these traits. 104 CCNL1 encodes a regulator of gene transcrip tion and premRNA splicing. The menarche ageraising allele has also been associated with a reduced insulin response and disposition index following an oral glucose challenge, 105 possibly supporting a role of insulin secre tion in the promotion of heavier birth weight and earlier puberty, but the mechanism remains unclear.
T2DM and cardiovascular disease
Epidemiological evidence indicates that nonlinear rela tionships exist between pubertal timing and the risk of incident type 2 diabetes mellitus (T2DM) 106 and coro nary heart disease (CHD). 107 Early menarche is associ ated with increased risks of T2DM and CHD, whereas late menarche has neutral effects on T2DM and confers an increased risk of CHD. 106, 107 Some of these relation ships might be explained by overweight and obesity, which promote both earlier puberty and increased disease risks; however, the disease associations remain evident after adjustments for BMI. Early menopause is a wellestablished risk factor for cardiovascular disease, owing to early loss of the protective effects of estrogen but also other mechanisms, 108 and a linear inverse associ ation seems to exist between age at menopause and the risk of T2DM, which is independent of BMI. 109 GWAS findings have implicated both BMIdependent and BMIindependent mechanisms that could plausi bly link the timing of menarche to T2DM risk. These include direct actions of the Lin28-let7 axis on insulin sensi tivity and glucose homeostasis, 110 and GABA B receptor signalling or cell cycle efficiency affecting βcell mass. 111 Emerging evidence also exists for a shared genetic aetiol ogy of reproductive ageing and lipid regu lation, highlighted by the role of steroidogenic acute regulatory protein (STAR) genes in both the timing of menarche (STARD4) 41 and menopause (STAR and STARD3). 13 Proteins in this family are key regulators of steroid hormone synthesis by facilitating the conver sion of chol esterol to the androgen and estrogen pre cursor pre neno lone. Disease associations with age at menopause might reflect both beneficial and adverse effects of sex steroid exposure. In addition, the identifi cation of a GWAS locus for menopausal timing at GCKR suggests a role for gluco kinase regulation and glucose sensing in reproductive ageing as well as in T2DM, CVD and dyslipidaemia. 112 Breast cancer Strong epidemiological evidence exists that links a longer reproductive lifespan (indicated in women by early puberty and delayed menopause) to increased risks of sexhormonesensitive cancers, particularly hormonereceptorpositive breast cancer. 113 These observational links are supported by genetic evidence of a causal relationship between delayed natural meno pause and an increased risk of breast cancer. These genetic findings also suggest that women with later menopause have more efficient DDR mechanisms than women who undergo menopause earlier. Their increased susceptibility to breast cancer, therefore, probably indi cates mechanisms other than DDR are involved, the foremost candidate mechanism being a longterm, lifetime, exposure to estrogens and/or progesterone. 13 
Conclusions
Genetic studies, using diverse approaches that capture common, lowfrequency or rare variants, have identified hundreds of loci and genes that regulate the timing of female reproductive ageing. Although these new find ings have only incrementally explained the population variance in the timing of puberty and menopause, owing to small effect sizes or low allele frequencies, the wealth of genetic association signals provides substantially greater capacity to identify the underlying biological mech an isms. These emerging findings provide evidence of shared genetic aetiologies, and hence shared biological mechanisms, linking the milestones of female reproduc tive ageing, and also linking the timing of reproductive ageing to various disease risks.
